Skip to main content

Molecular Devices Distributing De Novo Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Molecular Devices will distribute De Novo Software's FCS Express 4 software under a licensing agreement announced today.

Under the terms of the deal, Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide. Further terms of the deal were not disclosed.

In FCS Express 4, analytical tools for flow and image cytometry and high-content screening are combined in one environment with report generation and online collaboration tools, the companies said. The software, which was launched by De Novo in January, adds the ability to access and interactively perform population-based analysis, while linking back to the individual images underlying the data.

"This enables highlighting of individual cells in an image from selected populations or display of single cells of interest in separate cell galleries," Molecular Devices and De Novo said in a joint statement. The tools improve assay development and workflow and enable rapid report generation, they added.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.